NCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
Clinical Trials
4 trialsNCT01191034 2019-03-12
Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Terminated
NCT01538901 2017-09-12
AKtransplant
Medical University of Vienna
Phase 4 Terminated
NCT01203878 2014-12-08
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Tennessee Clinical Research Center
Phase 4 Terminated